Posters/Presentations The Role of sFRP1 in Conventional Renal Cell Carcinoma  Potential new drug therapies in advanced renal cell carcinoma: A Potential new drug therapies in advanced renal cell carcinoma: An investigation of different combinatory drug regimens on the prol investigation of different combinatory drug regimens on the proliferation of iferation of cultured human renal cell carcinoma cells cultured human renal cell carcinoma cells.  Single agent and combinatorial therapy of a novel high affinity PPARY agonist inhibit human anaplastic thyroid tumor growth  Type III TGFβ receptor is a tumor suppressor in human renal cell carcinoma |
Legal restrictions and terms of use applicable to this site
Use of this site signifies your agreement to the terms of use
Copyright © 2008 Mayo Foundation for Medical Education and Research.